Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment

VJ Clemente-Suárez, A Martín-Rodríguez… - International Journal of …, 2023 - mdpi.com
Mitochondrial dysfunction is a hallmark of numerous diseases, including neurodegenerative
disorders, metabolic disorders, and cancer. Mitochondrial transfer, the transfer of …

Redefining autoimmune disorders' pathoetiology: implications for mood and psychotic disorders' association with neurodegenerative and classical autoimmune …

G Anderson, AF Almulla, RJ Reiter, M Maes - Cells, 2023 - mdpi.com
Although previously restricted to a limited number of medical conditions, there is a growing
appreciation that 'autoimmune'(or immune-mediated) processes are important aspects of a …

Mitochondria-targeted delivery strategy of dual-loaded liposomes for Alzheimer's disease therapy

L Vasileva, G Gaynanova, F Valeeva… - International Journal of …, 2023 - mdpi.com
Liposomes modified with tetradecyltriphenylphosphonium bromide with dual loading of α-
tocopherol and donepezil hydrochloride were successfully designed for intranasal …

Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities

VJ Clemente-Suárez, L Redondo-Flórez… - Biomedicines, 2023 - mdpi.com
Mitochondria play a vital role in maintaining cellular energy homeostasis, regulating
apoptosis, and controlling redox signaling. Dysfunction of mitochondria has been implicated …

Mitochondrial Dysfunction as the Major Basis of Brain Aging

SC Bondy - Biomolecules, 2024 - mdpi.com
The changes in the properties of three biological events that occur with cerebral aging are
discussed. These adverse changes already begin to develop early in mid-life and gradually …

Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease

Y Yang, X Jia, X Yang, J Wang, Y Fang, X Ying… - Brain Research, 2024 - Elsevier
Mitochondrial dysfunction has been implicated in the pathogenesis of Alzheimer's disease, a
neurodegenerative disorder characterized by progressive cognitive decline. Voltage …

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants

PN Tripathi, A Lodhi, SN Rai, NK Nandi… - Degenerative …, 2024 - Taylor & Francis
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, memory loss, and impaired daily functioning. While there is currently no …

Oleoylethanolamide improves energy disposal in a cellular model of Alzheimer's disease

A Quentin, F Dieter, M Reutzel… - Journal of Mitochondria …, 2024 - Taylor & Francis
Oleoylethanolamide (OEA) is an endogenous lipid mediator which is being discussed as a
weight-loss drug for obesity. In addition to its homoeostatic functions, OEA has …

The long term effects of uncoupling interventions as a therapy for dementia in humans

AG Holt, AM Davies - Journal of Theoretical Biology, 2024 - Elsevier
In this paper we use simulation methods to study a hypothetical uncoupling agent as a
therapy for dementia. We simulate the proliferation of mitochondrial deletion mutants …

The Mitochondrion as the Major Basis of Brain Aging

SC Bondy - 2024 - preprints.org
The changes in the properties of three biological events, that occur with cerebral aging, are
discussed. These adverse changes already begin to develop early in mid-life and gradually …